Status:
RECRUITING
Long-term of Remote Ischemic Preconditioning in Patients With Mild Hypertension
Lead Sponsor:
Henan Institute of Cardiovascular Epidemiology
Conditions:
Hypertension
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
According to the latest survey data of China hypertension annual meeting, there are about 300 million patients with hypertension in China, with 10 million new cases of hypertension each year, and ther...
Detailed Description
A total of 200 patients with mild hypertension were enrolled in this study, using the method of open label and parallel grouping; 100 cases in the experimental group and 100 cases in the control group...
Eligibility Criteria
Inclusion
- Diagnosed patients with mild hypertension (SBP: 140\~159mmHg; DBP: 90\~99mmHg)
Exclusion
- Cannot tolerate RIPC
- Non-essential hypertension
- patients who have uncontrolled severe arrhythmia, diabetes, electrolyte disturbance
- patients who have severe organic diseases such acute myocardial infarction, cardiac insufficiency, abnormal renal function, etc.
Key Trial Info
Start Date :
July 3 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04753840
Start Date
July 3 2021
End Date
December 1 2030
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fuwai central China Cardiovascular hospital
Zhengzhou, Henan, China, 450008